Hanns Möhler

Title: Hanns Möhler: Innovator in Hepatic Encephalopathy Treatment

Introduction

Hanns Möhler is a notable inventor based in Maennedorf, Switzerland. He has made significant contributions to the field of medicine with his innovative patents. With a total of two patents to his name, Möhler is focused on developing treatments for hepatic encephalopathy, showcasing his dedication to improving healthcare.

Latest Patents

Möhler's latest patents revolve around steroid compounds designed for the treatment of hepatic encephalopathy. One such patent describes the steroidal compound 3α-ethynyl-3β-hydroxyandrostan-17-one oxime, or a pharmaceutically acceptable salt thereof, for use in the treatment of this condition. This invention holds potential in addressing the critical challenges faced by patients suffering from hepatic encephalopathy.

Career Highlights

Möhler is affiliated with Umecrine Cognition AB, where his innovative work contributes to advances in medical treatment. His contributions have established him as a valuable asset in the research and development of essential therapeutic solutions.

Collaborations

In his professional journey, Möhler has collaborated with notable colleagues like Magnus Doverskog and Vicente Felipo. These collaborations foster an environment of innovation and creativity, enhancing the development of effective treatments.

Conclusion

Hanns Möhler’s work exemplifies the intersection of research and innovation in medicine. His patents not only reflect his inventive spirit but also highlight his commitment to tackling pressing health issues, particularly hepatic encephalopathy. Through his endeavors at Umecrine Cognition AB, Möhler is making strides that could positively impact many lives.